Immutep (IMMP) Stock Price, Quote, News & History

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$2.00

$2.27

Volume / Avg.

29.08M / 586.95K

Day Range

$2.00 - $3.53

52 Wk Range

1.32 - 3.53

Market Cap

$316.93M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

3.22%

Days to Cover

38.36

Recent Immutep Ltd News

Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo

Immutep's efti combo with Keytruda and chemo shows a 60.8% response rate in lung cancer trial, with strong efficacy across PD-L1 expression levels.

Vandana Singh

Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial

Immutep's INSIGHT-003 Phase 1 trial reports promising survival data for 1L NSCLC treatment using eftilagimod alpha, Keytruda, and chemotherapy.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$2.00

$2.27

Volume / Avg.

29.08M / 586.95K

Day Range

$2.00 - $3.53

52 Wk Range

1.32 - 3.53

Market Cap

$316.93M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

3.22%

Days to Cover

38.36

About

Sector

Health Care

Industry

Biotechnology

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stim...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry